This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Probiotics and Infections in Children Attending Day Care Centres

This study has been completed.
Helsinki University
Information provided by:
Valio Ltd Identifier:
First received: November 16, 2009
Last updated: July 6, 2011
Last verified: July 2011
The purpose of this study is to evaluate the effect of regular consumption of probiotic milk in preventing illnesses in Finnish children attending day care centres, and possible cost-benefits that could be associated with fewer illnesses.

Condition Intervention Phase
Respiratory Tract Infections Gastrointestinal Diseases Dietary Supplement: Probiotic Other: Placebo Phase 3

Study Type: Interventional

Further study details as provided by Valio Ltd:

Arms Assigned Interventions
Active Comparator: Probiotic milk Dietary Supplement: Probiotic
Placebo Comparator: Standard milk Other: Placebo


Ages Eligible for Study:   2 Years to 6 Years   (Child)
Sexes Eligible for Study:   All

Inclusion Criteria:

  • Age 2 to 6 years in the beginning of the intervention
  • Attendance at a day care centre participating in the study (5 days a week)

Exclusion Criteria:

  • Milk allergy or lactose intolerance
  • Congenital heart diseases that requires regular medication
  • Malign diseases
  • Cytostatic treatment
  • Use of biological rheumatic medication
  • Continuous microbial medication
  • Regular use of oral corticosteroids (inhalable accepted)
  • Diabetes
  • Simultaneous participation in other clinical trials
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01014676

Clinical Life Sciences Inc.
Kajaani and Oulu, Province of Oulu, Finland
Sponsors and Collaborators
Valio Ltd
Helsinki University
Principal Investigator: Anne Pitkäranta, Professor Helsinki University Central Hospital
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT01014676     History of Changes
Other Study ID Numbers: Valio-69
Study First Received: November 16, 2009
Last Updated: July 6, 2011

Keywords provided by Valio Ltd:
Costs and Cost Analysis

Additional relevant MeSH terms:
Respiratory Tract Infections
Gastrointestinal Diseases
Digestive System Diseases
Respiratory Tract Diseases processed this record on July 21, 2017